Upgrades/Downgrades
Updated: 03-Jul-25 16:30 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| UPS | UPS | BNP Paribas Exane | Underperform » Neutral | $100 | |
| Valley National | VLY | Morgan Stanley | Equal-Weight » Overweight | $11 | |
| Meta Platforms | META | Needham | Underperform » Hold | ||
| Huntington Banc | HBAN | Wolfe Research | Peer Perform » Outperform | $21 | |
| FedEx | FDX | BNP Paribas Exane | Underperform » Outperform | $270 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| NV5 Global | NVEE | Maxim Group | Buy » Hold | ||
| Two Harbors Investment | TWO | Citizens JMP | Mkt Outperform » Mkt Perform | ||
| Rio Tinto | RIO | Berenberg | Buy » Hold | ||
| PNC | PNC | Wolfe Research | Outperform » Peer Perform | ||
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Primoris Services | PRIM | Janney | Buy | ||
| Telix Pharmaceuticals | TLX | H.C. Wainwright | Buy | $23 | |
| Ralliant Corporation | RAL | BofA Securities | Underperform | $48 | |
| Prairie Operating Co. | PROP | KeyBanc Capital Markets | Sector Weight | ||
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Disc Medicine | IRON | Morgan Stanley | Overweight | $85 | |
| Certara | CERT | Morgan Stanley | Equal-Weight | $16 | |
| BioMarin Pharmaceutical | BMRN | Morgan Stanley | Overweight | $97 | |
| Schrodinger | SDGR | Morgan Stanley | Equal-Weight | $28 | |
| Sana Biotechnology | SANA | Morgan Stanley | Overweight | $12 | |
| Recursion Pharmaceuticals | RXRX | Morgan Stanley | Equal-Weight | $5 | |
| Kymera Therapeutics | KYMR | Morgan Stanley | Overweight | $70 | |
| Axsome Therapeutics | AXSM | Morgan Stanley | Overweight | $190 | |
| Ascendis Pharma | ASND | Morgan Stanley | Overweight | $250 | |
| argenx | ARGX | Morgan Stanley | Overweight | $700 | |
| Absci Corporation | ABSI | Morgan Stanley | Overweight | $7 | |
|
|
|||||
| Coverage Reiterated/Price Tgt Changed* | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Crown | CCK | Citigroup | Buy | $119 » $129 | |
| DuPont | DD | Citigroup | Buy | $75 » $85 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |